The low expression of TRAPα may be due to the abnormality in the modification and transport of the peptide chain, resulting in liver damage, which affects the normal progress of subsequent life activities and leads to the occurrence and development of fatty liver. The gene discussed is SSR1; the disease is fatty liver disease.